Paper2804973
Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues.
Chambers SK and 4 others. Cancer Res, 1989. Cited by 51 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Enhancement of anthracycline growth inhibition in parent and multidrug-resistant Chinese hamster ovary cells by cyclosporin A and its analogues. Papers, record 2804973. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2804973
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Division | Major topic |
| Cyclosporins | Major topic |
| DNA Damage | Major topic |
| Doxorubicin | Major topic |
| Animals | |
| Cell Line | |
| Cricetinae | |
| Cricetulus | |
| DNA, Single-Stranded | |
| Drug Resistance | |
| Epirubicin | |
| Female | |
| Kinetics | |
| Ovary | |
| Structure-Activity Relationship |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CA 43888 | NCI NIH HHS | United States | R01CA043888 | PubMed and NIH |
Source NIH RePORTER
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 51 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 26688098 | Recapitulation of complex transport and action of drugs at the tumor microenvironment using tumor-microenvironment-on-chip. | Cancer Lett | 2016 | https://conductscience.org/library/papers/26688098 | PubMed |
| 24926353 | Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells. | Exp Ther Med | 2014 | https://conductscience.org/library/papers/24926353 | PubMed |
| 16925584 | Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells. | Cancer Sci | 2006 | https://conductscience.org/library/papers/16925584 | PubMed |
| 8431967 | Modulation of drug cytotoxicity in wild-type and multidrug-resistant tumor cells by stereoisomeric series of C-20'-vinblastine congeners that lack antimicrotubule activity. | Cancer Chemother Pharmacol | 1993 | https://conductscience.org/library/papers/8431967 | PubMed |
| 8281626 | Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/8281626 | PubMed |
| 8251651 | Expression of mdr1 gene in human breast primary tumors and metastases. | Breast Cancer Res Treat | 1993 | https://conductscience.org/library/papers/8251651 | PubMed |
| 8098047 | Sensitivity of K562 human chronic myelogenous leukemia blast cells transfected with a human multidrug resistance cDNA to cytotoxic drugs and differentiating agents. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8098047 | PubMed |
| 7907333 | Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA. | J Cancer Res Clin Oncol | 1994 | https://conductscience.org/library/papers/7907333 | PubMed |
| 7773504 | Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells. | Virchows Arch | 1995 | https://conductscience.org/library/papers/7773504 | PubMed |
| 7765325 | Pharmacologic circumvention of multidrug resistance. | Cytotechnology | 1993 | https://conductscience.org/library/papers/7765325 | PubMed |
| 7635870 | Reversal of multidrug resistance by novel cyclosporin A analogues and the cyclopeptolide SDZ 214-103 biosynthesized in vitro. | J Cancer Res Clin Oncol | 1995 | https://conductscience.org/library/papers/7635870 | PubMed |
| 2390489 | Cyclosporin A and verapamil have different effects on energy metabolism in multidrug-resistant tumour cells. | Br J Cancer | 1990 | https://conductscience.org/library/papers/2390489 | PubMed |
| 1671752 | Reversal of intrinsic multidrug resistance in Chinese hamster ovary cells by amiloride analogs. | Br J Cancer | 1991 | https://conductscience.org/library/papers/1671752 | PubMed |
| 1313690 | Effects of cyclosporin A and a non-immunosuppressive analogue, O-acetyl cyclosporin A, upon the growth of parent and multidrug resistant human lung cancer cells in vitro. | Br J Cancer | 1992 | https://conductscience.org/library/papers/1313690 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2804973
GET https://conductscience.org/api/papers/v1/2804973/authors